Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab.

Authors	Francesco Pantano, Marianna Silletta, Alfonso Iovieno, Bruno Vincenzi, Daniele Santini, Sara Galluzzo, Stefano Bonini, Giuseppe Tonini
Journal	International journal of colorectal disease (Int J Colorectal Dis) Vol. 24 Issue 10 Pg. 1247-8 (Oct 2009) ISSN: 1432-1262 [Electronic] Germany
PMID	19225787 (Publication Type: Letter)
Chemical References	Antibodies, Monoclonal Antibodies, Monoclonal, Humanized panitunumab Cetuximab
Topics	Antibodies, Monoclonal (adverse effects, therapeutic use) Antibodies, Monoclonal, Humanized Cetuximab Female Humans Lung Neoplasms (drug therapy, secondary) Middle Aged Stevens-Johnson Syndrome (etiology) Tears (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!